Covidh Technologies Ltd

$COVIDHComputers - Software & ConsultingBSE

Covidh Technologies Ltd (COVIDH) last traded at ₹144, a market capitalisation of ₹121 crore. Over the past 52 weeks the stock has ranged between ₹5.31 and ₹144. Covidh Technologies Ltd last reported results for the quarter ended Jun 2019, with sales of ₹1.11 crore and net profit of ₹-0.06 crore. Figures are as of 25 Aug 2026 and are not real time.

Covidh Technologies Ltd share price and key metrics

Current price
₹144
Market cap
₹121 cr
Book value
₹0.02
ROE
-7.92%
ROCE
3.40%
Dividend yield
0.00%
52w high / low
144/5.31

Metrics as of 25 Aug 2026. Not real time.

Covidh Technologies Ltd quarterly results

In the quarter ended Jun 2019, sales were ₹1.11 cr, down 89.4% from ₹10.43 cr a year earlier. Net profit swung to a loss of ₹0.06 cr.

Covidh Technologies Ltd consolidated quarterly results, figures in ₹ crore
₹ croreJun 2015Sep 2015Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019
Sales4.436.2413.7910.437.424.213.621.11
Expenses4.236.0213.5910.357.324.123.411.11
Operating profit0.20.220.20.080.10.090.210
OPM %4.51%3.53%1.45%0.77%1.35%2.14%5.80%0.00%
Other income00000000
Interest000.090.050.110.090.130.06
Depreciation0.090.090.1200.020.010.090
Profit before tax0.110.13-0.010.03-0.03-0.01-0.01-0.06
Tax %27.27%30.77%-100.00%33.33%0.00%0.00%100.00%0.00%
Net profit0.080.0900.02-0.03-0.01-0.03-0.06
EPS (₹)0.000.000.000.00-0.00-0.00-0.00-0.00

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Covidh Technologies Ltd annual results

Covidh Technologies Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2013Mar 2014Mar 2015Mar 2016Mar 2018Mar 2019TTM
Sales25.8535.8911.0625.533.5725.6916.36
Operating profit3.110.520.780.360.470.480.4
OPM %12.03%1.45%7.05%1.41%1.40%1.87%2.44%
Net profit1.930.110.13-13.420.01-0.04-0.13
EPS (₹)0.070.000.00-0.490.00-0.000.00

TTM is the trailing twelve months to the most recent quarter.

Covidh Technologies Ltd growth and returns

Compounded Sales Growth
10 Years
%
5 Years
-6%
3 Years
0%
TTM
-23%
Compounded Profit Growth
10 Years
%
5 Years
%
3 Years
-13%
TTM
-500%
Stock Price CAGR
10 Years
43%
5 Years
173%
3 Years
313%
1 Year
2662%
Return on Equity
10 Years
%
5 Years
%
3 Years
%
Last Year
-8%

Covidh Technologies Ltd shareholding pattern

Promoters held 58.63% at Jun 2026, down from 92.76% at Jun 2025.

Covidh Technologies Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters26.35%26.35%92.76%92.76%92.76%3.57%58.63%58.63%
Public73.65%73.65%7.24%7.24%7.24%96.43%41.38%41.37%
No. of shareholders2,5302,5309329329361,0341,0291,014

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Covidh Technologies Ltd corporate filings

  • We hereby submit the monitoring Agency Report for utilization of proceeds of Rights Issue of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the quarter ended ....Company Updatelow impact
    Filing PDF

    Cruxal's analysis: iSERA Lifesciences Limited has submitted its Monitoring Agency Report for the quarter…

    Read the full analysis
  • We are hereby submitting the Unaudited Financial Results of the Company for the quarter ended June 30, 2026.Resulthigh impact
    Filing PDF

    Cruxal's analysis: iSERA Lifesciences Limited reported nil revenue from operations for the quarter ended…

    Read the full analysis
  • Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the Board of Directors of the Company at its meeting held on ....Board Meetinghigh impact
    Filing PDF

    Cruxal's analysis: iSERA Lifesciences Limited has released its unaudited financial results for the quarter…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Covidh Technologies Ltd

Cruxal reads every Covidh Technologies Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.